SCHEMBL7361156

SCHEMBL7361156

CS(=O)(=O)C1=NC(c2ccccc2)=C[N]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 13/20 0.40
HPGD P15428 3/20 0.38
ALDH1A1 P00352 3/20 0.38
BPTF Q12830 1/20 0.35
PTGS1 P23219 1/20 0.35
LMNA P02545 2/20 0.34
HTT P42858 2/20 0.34
KMT2A Q03164 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
MEN1 O00255 1/20 0.34
S1PR4 O95977 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
S1PR1 P21453 1/20 0.34
SDHB P21912 1/20 0.34
MAPK1 P28482 1/20 0.34
STAT3 P40763 1/20 0.34
STAT1 P42224 1/20 0.34
RAB9A P51151 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7354281 0.81 PTGS2 (0.48) PTGS2HPGDALDH1A1PTGS1LMNA
SCHEMBL7350512 0.76
SCHEMBL7349788 0.76
Biphenyl SCHEMBL134068 0.66 ALDH1A1 (0.60) PTGS2ALDH1A1MAPK1SMN1; SMN2
SCHEMBL7392082 0.64 ALDH1A1 (0.42) HPGDALDH1A1LMNAKMT2AMEN1
SCHEMBL7356907 0.64 PTGS1 (0.38) PTGS2HPGDALDH1A1PTGS1KMT2A
Biphenyl SCHEMBL27509992 0.62 CA2 (0.61) PTGS2ALDH1A1RAB9AHSD17B10TDP1
Biphenyl SCHEMBL21462355 0.62 ALDH1A1 (0.53) PTGS2ALDH1A1RAB9AGAASMN1; SMN2
SCHEMBL1687503 0.61 PTGS2 (0.79) PTGS2PTGS1
SCHEMBL8770202 0.61 PTGS2 (0.79) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999032454-A9 NITROGEN CONTAINING HETEROAROMATICS WITH ORTHO-SUBSTITUTED P1'S AS FACTOR XA INHIBITORS DU PONT PHARM CO (US) 2001-05-31 WO disclosed
EP-1064270-A2 DISUBSTITUTED PYRAZOLINES AND TRIAZOLINES AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-01-03 EP disclosed
EP-1042299-A1 NITROGEN CONTAINING HETEROAROMATICS WITH ORTHO-SUBSTITUTED P1'S AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2000-10-11 EP disclosed
CN-1246847-A Nitrogen containing heteroaromatics as factor Xa inhibitors DU PONT MERCK PHARMA (US) 2000-03-08 CN disclosed
WO-1999050255-A2 DISUBSTITUTED PYRAZOLINES AND TRIAZOLINES AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-07 WO disclosed
EP-0946508-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
EP-0946528-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
WO-1999032454-A1 NITROGEN CONTAINING HETEROAROMATICS WITH ORTHO-SUBSTITUTED P1'S AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1999-07-01 WO disclosed
WO-1998028282-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed
WO-1998028269-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed